PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma
Article in European Journal of Medical Research (March 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Article in European Journal of Medical Research (March 2024)
Article in Journal of Hepatocellular Carcinoma (November 2023)
Article in Biomedicines (July 2023)